OTCMKTS:ERRFY Eurofins Scientific (ERRFY) Stock Price, News & Analysis $11.99 +1.99 (+19.90%) As of 05/11/2021 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Eurofins Scientific Stock (OTCMKTS:ERRFY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Eurofins Scientific alerts:Sign Up Key Stats Today's Range$11.99▼$11.9950-Day Range$11.99▼$11.9952-Week Range$3.03▼$30.00Volume100 shsAverage Volume12,799 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm offers testing and laboratory services for agro science, genomics, discovery pharmacology and for supporting clinical studies. It operates through the following geographical segments: Europe, North America, and Rest of the World. The company was founded by Gilles G. Martin in 1987 and is headquartered in Luxembourg. Read More Receive ERRFY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eurofins Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address ERRFY Stock News HeadlinesEurofins Scientific SE: Director/PDMR ShareholdingJuly 11, 2025 | businesswire.comEurofins Scientific SE (ERFSF) Q2 2025 Earnings Call TranscriptApril 23, 2025 | seekingalpha.comHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.August 25 at 2:00 AM | The Oxford Club (Ad)Temu boosts product safety and compliance with Eurofins partnershipApril 8, 2025 | msn.comTemu Partners With Eurofins to Shore Up Product Safety and ComplianceApril 8, 2025 | msn.comEurofins targets 6.5% organic growth through 2027 with margin optimizationJanuary 30, 2025 | msn.comThe Noise Has Been Loud Lately, But At The Deepest Level Eurofins Is UnchangedJanuary 30, 2025 | seekingalpha.comKepler Capital Keeps Their Buy Rating on Eurofins Scientific (0MV5)November 16, 2024 | markets.businessinsider.comSee More Headlines ERRFY Stock Analysis - Frequently Asked Questions How have ERRFY shares performed this year? Eurofins Scientific's stock was trading at $11.99 on January 1st, 2025. Since then, ERRFY shares have increased by 0.0% and is now trading at $11.99. How do I buy shares of Eurofins Scientific? Shares of ERRFY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Services To The Health Industry Sub-IndustryN/A Current SymbolOTCMKTS:ERRFY CIKN/A WebN/A Phone(522) 618-5320FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:ERRFY) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eurofins Scientific SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Eurofins Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.